ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

Identifying patients with locally advanced head and neck carcinoma on high risk of recurrence after definitive concurrent radiochemotherapy is of key importance for the selection for consolidation therapy and for individualized treatment intensification. In this multicenter study we analyzed recurre...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pharmacogenomics J
Главные авторы: Guberina, Maja, Sak, Ali, Pöttgen, Christoph, Tinhofer-Keilholz, Ingeborg, Budach, Volker, Balermpas, Panagiotis, Von der Grün, Jens, Rödel, Claus Michael, Gkika, Eleni, Grosu, Anca-Ligia, Abdollahi, Amir, Debus, Jürgen, Belka, Claus, Pigorsch, Steffi, Combs, Stephani E., Mönnich, David, Zips, Daniel, De-Colle, Chiara, Welz, Stefan, Linge, Annett, Lohaus, Fabian, Baretton, Gustavo, Gauler, Thomas, Baumann, Michael, Krause, Mechthild, Schuler, Martin, Bankfalvi, Agnes, Höing, Benedikt, Lang, Stephan, Stuschke, Martin
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840506/
https://ncbi.nlm.nih.gov/pubmed/32546699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41397-020-0174-1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы